FOLH1 and pancreatic neoplasm: In particular, Krishnaraju et al. compared 68Ga-PSMA and 18F-FDG PET/CT results in a patient with a newly diagnosed pancreatic mass, reporting high overall sensitivity for both radiopharmaceuticals (94.7% vs. 89.5%) and higher specificity for PSMA (90% vs. 57.1%) for the detection of the primary pancreatic tumor; the authors concluded that 68Ga-PSMA PET/CT imaging may be more accurate in the pre-operative setting, when an early diagnosis and surgical resection can strongly improve the clinical outcome of the patients with localized disease [96].